BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18667502)

  • 1. Sequestering of the prehairpin intermediate of gp41 by peptide N36Mut(e,g) potentiates the human immunodeficiency virus type 1 neutralizing activity of monoclonal antibodies directed against the N-terminal helical repeat of gp41.
    Gustchina E; Bewley CA; Clore GM
    J Virol; 2008 Oct; 82(20):10032-41. PubMed ID: 18667502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal Fab derived from a human nonimmune phage library reveals a new epitope on gp41 and neutralizes diverse human immunodeficiency virus type 1 strains.
    Gustchina E; Louis JM; Lam SN; Bewley CA; Clore GM
    J Virol; 2007 Dec; 81(23):12946-53. PubMed ID: 17898046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41.
    Bewley CA; Louis JM; Ghirlando R; Clore GM
    J Biol Chem; 2002 Apr; 277(16):14238-45. PubMed ID: 11859089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of HIV-1 gp41-directed neutralizing and non-neutralizing fragment antibody binding domain (Fab) and single chain variable fragment (ScFv) antibodies to the ectodomain of gp41 in the pre-hairpin and six-helix bundle conformations.
    Louis JM; Aniana A; Lohith K; Sayer JM; Roche J; Bewley CA; Clore GM
    PLoS One; 2014; 9(8):e104683. PubMed ID: 25105806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity maturation by targeted diversification of the CDR-H2 loop of a monoclonal Fab derived from a synthetic naïve human antibody library and directed against the internal trimeric coiled-coil of gp41 yields a set of Fabs with improved HIV-1 neutralization potency and breadth.
    Gustchina E; Louis JM; Frisch C; Ylera F; Lechner A; Bewley CA; Clore GM
    Virology; 2009 Oct; 393(1):112-9. PubMed ID: 19695655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and HIV-1 fusion inhibitory properties of monoclonal Fabs obtained from a human non-immune phage library selected against diverse epitopes of the ectodomain of HIV-1 gp41.
    Louis JM; Bewley CA; Gustchina E; Aniana A; Clore GM
    J Mol Biol; 2005 Nov; 353(5):945-51. PubMed ID: 16216270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of HIV-1 neutralization by affinity matured Fabs directed against the internal trimeric coiled-coil of gp41.
    Gustchina E; Li M; Louis JM; Anderson DE; Lloyd J; Frisch C; Bewley CA; Gustchina A; Wlodawer A; Clore GM
    PLoS Pathog; 2010 Nov; 6(11):e1001182. PubMed ID: 21085615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics.
    Nelson JD; Kinkead H; Brunel FM; Leaman D; Jensen R; Louis JM; Maruyama T; Bewley CA; Bowdish K; Clore GM; Dawson PE; Frederickson S; Mage RG; Richman DD; Burton DR; Zwick MB
    Virology; 2008 Jul; 377(1):170-83. PubMed ID: 18499210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Derivative of the D5 Monoclonal Antibody That Targets the gp41 N-Heptad Repeat of HIV-1 with Broad Tier-2-Neutralizing Activity.
    Rubio AA; Filsinger Interrante MV; Bell BN; Brown CL; Bruun TUJ; LaBranche CC; Montefiori DC; Kim PS
    J Virol; 2021 Jul; 95(15):e0235020. PubMed ID: 33980592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies.
    Chakrabarti BK; Pancera M; Phogat S; O'Dell S; McKee K; Guenaga J; Robinson J; Mascola J; Wyatt RT
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):877-87. PubMed ID: 21158699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.
    Nelson JD; Brunel FM; Jensen R; Crooks ET; Cardoso RM; Wang M; Hessell A; Wilson IA; Binley JM; Dawson PE; Burton DR; Zwick MB
    J Virol; 2007 Apr; 81(8):4033-43. PubMed ID: 17287272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
    Bryson S; Julien JP; Isenman DE; Kunert R; Katinger H; Pai EF
    J Mol Biol; 2008 Oct; 382(4):910-9. PubMed ID: 18692506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiency virus type 1 gp41.
    Gorny MK; Zolla-Pazner S
    J Virol; 2000 Jul; 74(13):6186-92. PubMed ID: 10846104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens.
    Zhang MY; Vu BK; Choudhary A; Lu H; Humbert M; Ong H; Alam M; Ruprecht RM; Quinnan G; Jiang S; Montefiori DC; Mascola JR; Broder CC; Haynes BF; Dimitrov DS
    J Virol; 2008 Jul; 82(14):6869-79. PubMed ID: 18480433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of a non-neutralizing antibody to the HIV-1 gp41 membrane-proximal external region.
    Nicely NI; Dennison SM; Spicer L; Scearce RM; Kelsoe G; Ueda Y; Chen H; Liao HX; Alam SM; Haynes BF
    Nat Struct Mol Biol; 2010 Dec; 17(12):1492-4. PubMed ID: 21076400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress towards the development of a HIV-1 gp41-directed vaccine.
    McGaughey GB; Barbato G; Bianchi E; Freidinger RM; Garsky VM; Hurni WM; Joyce JG; Liang X; Miller MD; Pessi A; Shiver JW; Bogusky MJ
    Curr HIV Res; 2004 Apr; 2(2):193-204. PubMed ID: 15078183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel ring structure in the gp41 trimer of human immunodeficiency virus type 1 that modulates sensitivity and resistance to broadly neutralizing antibodies.
    O'Rourke SM; Schweighardt B; Scott WG; Wrin T; Fonseca DP; Sinangil F; Berman PW
    J Virol; 2009 Aug; 83(15):7728-38. PubMed ID: 19474108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.
    Finnegan CM; Berg W; Lewis GK; DeVico AL
    J Virol; 2002 Dec; 76(23):12123-34. PubMed ID: 12414953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexes of neutralizing and non-neutralizing affinity matured Fabs with a mimetic of the internal trimeric coiled-coil of HIV-1 gp41.
    Gustchina E; Li M; Ghirlando R; Schuck P; Louis JM; Pierson J; Rao P; Subramaniam S; Gustchina A; Clore GM; Wlodawer A
    PLoS One; 2013; 8(11):e78187. PubMed ID: 24244293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.
    Zwick MB; Labrijn AF; Wang M; Spenlehauer C; Saphire EO; Binley JM; Moore JP; Stiegler G; Katinger H; Burton DR; Parren PW
    J Virol; 2001 Nov; 75(22):10892-905. PubMed ID: 11602729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.